+987.9%
MRNA vs CHRW
-10.6%
+998.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CHRW | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +0.2% | +12.9% | +13.1% |
| 7D | +20.6% | +4.9% | +15.8% | +20.3% |
| 30D | +27.1% | -4.8% | +32.0% | +27.5% |
| 3M | +353.4% | -13.1% | +366.5% | +356.0% |
| 6M | +446.3% | -16.3% | +462.6% | +439.9% |
| YTD | +776.2% | -15.8% | +792.0% | +673.0% |
| 1Y | +987.9% | -11.1% | +999.1% | +835.3% |
| All | +987.9% | -10.6% | +998.5% | +835.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CHRW.
Daily Out/Under-Performance
Portfolio return minus CHRW return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHRW return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CHRW wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling